Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chemocentryx Inc (CCXI)

Chemocentryx Inc (CCXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,833,903
  • Shares Outstanding, K 58,048
  • Annual Sales, $ 42,880 K
  • Annual Income, $ -37,970 K
  • 60-Month Beta 2.40
  • Price/Sales 78.17
  • Price/Cash Flow N/A
  • Price/Book 45.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.26
  • Number of Estimates 5
  • High Estimate -0.21
  • Low Estimate -0.32
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -23.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.85 +30.04%
on 01/27/20
51.36 -1.64%
on 02/19/20
+6.86 (+15.71%)
since 01/17/20
3-Month
7.88 +541.12%
on 11/22/19
51.36 -1.64%
on 02/19/20
+41.82 (+480.69%)
since 11/19/19
52-Week
6.16 +720.13%
on 08/06/19
51.36 -1.64%
on 02/19/20
+39.70 (+366.91%)
since 02/19/19

Most Recent Stories

More News
ChemoCentryx to Present at the 9th Annual SVB Leerink Global Healthcare Conference

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 9th Annual SVB Leerink Healthcare Conference on Wednesday, February...

CCXI : 50.52 (+3.48%)
SmarTrend Watching for Potential Rebound in Shares of Chemocentryx Inc After 3.57% Loss

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $47.13 to a high of $49.19. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of...

CCXI : 50.52 (+3.48%)
Watch for Chemocentryx Inc to Potentially Pullback After Gaining 4.81% Yesterday

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $42.59 to a high of $44.61. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high...

CCXI : 50.52 (+3.48%)
Chemocentryx Inc Shares Up 19.4% Since SmarTrend's Buy Recommendation (CCXI)

SmarTrend identified an Uptrend for Chemocentryx Inc (NASDAQ:CCXI) on November 26th, 2019 at $33.45. In approximately 2 months, Chemocentryx Inc has returned 19.42% as of today's recent price of $39.94....

CCXI : 50.52 (+3.48%)
Chemocentryx Inc Shares Up 30.5% Since SmarTrend's Buy Recommendation (CCXI)

SmarTrend identified an Uptrend for Chemocentryx Inc (NASDAQ:CCXI) on November 26th, 2019 at $33.45. In approximately 2 months, Chemocentryx Inc has returned 30.54% as of today's recent price of $43.66....

CCXI : 50.52 (+3.48%)
ChemoCentryx Announces Credit Facility of Up to $100 Million with Hercules Capital

ChemoCentryx, Inc., (NASDAQ: CCXI) today announced that the Company has secured a credit facility of up to $100 million provided by Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing...

CCXI : 50.52 (+3.48%)
HTGC : 15.21 (-0.46%)
ChemoCentryx to Present at the 38th Annual JP Morgan Healthcare Conference

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 38th Annual JP Morgan Healthcare Conference on Wednesday January...

CCXI : 50.52 (+3.48%)
Look for Shares of Chemocentryx Inc to Potentially Pullback after Yesterday's 2.08% Rise

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $37.63 to a high of $38.70. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high...

CCXI : 50.52 (+3.48%)
Look for Shares of Chemocentryx Inc to Potentially Rebound after Yesterday's 3.49% Sell Off

Chemocentryx Inc (NASDAQ:CCXI) traded in a range yesterday that spanned from a low of $33.25 to a high of $36.06. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of...

CCXI : 50.52 (+3.48%)
Relatively Good Performance Detected in Shares of Chemocentryx Inc in the Biotechnology Industry (CCXI , PBYI , CLVS , MNTA , ALXN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CCXI : 50.52 (+3.48%)
CLVS : 10.46 (+12.96%)
PBYI : 13.93 (+4.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CCXI with:

Business Summary

ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.

See More

Key Turning Points

2nd Resistance Point 52.81
1st Resistance Point 51.67
Last Price 50.52
1st Support Level 49.07
2nd Support Level 47.62

See More

52-Week High 51.36
Last Price 50.52
Fibonacci 61.8% 34.09
Fibonacci 50% 28.76
Fibonacci 38.2% 23.43
52-Week Low 6.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar